iSOFT Agrees New Five-Year Deals with iSOFT 7 Worth £12.6 Million

iSOFT Group LimitediSOFT Group Limited (ASX:ISF) said that the group of seven NHS trusts in England, known as the iSOFT 7, will extend their agreements for patient and clinical management systems for five years, in deals totalling £12.6 million.

The contracts are worth £4.8 million in licence fees and £7.8 million for maintenance and support and run to April 2016.

All seven are to extend contracts for iSOFT’s patient administration system (PAS). The four of these trusts that use iSOFT’s clinical management solution for order communications, results reporting and prescribing will also extend licenses, maintenance and support for a further five years. The trusts will take control of the contracts from NHS Connecting for Health.

The five NHS trusts in London and two in the south of England combined to agree the original deal in 2006.

"This is a hugely important development for iSOFT and one that demonstrates that these customers derive genuine value for money from our continued relationship," said Adrian Stevens, Managing Director of iSOFT's UK and Ireland business.

"We are also aware of our responsibility to provide real value to our customers," Stevens added. "These new agreements are a measure of this and our capacity to provide solutions and services to match customer needs."

"The iSOFT 7 rank among the country's most prestigious and innovative trusts and have again shown their confidence in our ability to deliver real value," said Andrea Fiumicelli, iSOFT's Chief Executive Officer. "We welcome the opportunity to continue the work we are doing jointly to further develop our solutions to optimize processes and workflows to find further efficiencies and savings and generally improve the quality of patient services and care."

The seven are: Great Ormond Street Hospital for Children NHS Trust; Kings College Hospital NHS Foundation Trust; Guys and St Thomas' NHS Foundation Trust; Epsom and St Helier NHS Trust; University Hospital Lewisham NHS Trust; Salisbury NHS Foundation Trust; and Plymouth Hospitals NHS Trust. All seven have used iSOFT's PAS solutions for over ten years.

Colin Sweeney, Director of IT at King's College, says the seven are planning to run iSOFT systems for the foreseeable future. "From our point of view, the clinical functionality offered under the national programme does not match what we already have from iSOFT.

"The precise details of the contract need to be agreed, but this is the best result possible as its causes the least disruption," he said. "The service is certainly an improvement on what we had before and at a price that the trusts feel is affordable."

Under the contracts, CSC delivered iSOFT's PAS as a managed service from its UK data centre.

A spokesperson for CSC told E-Health Insider: "CSC is committed to the healthcare market in the UK and view this contract as very important."

Related news articles:

About iSOFT Group
iSOFT Group Limited (ASX: ISF) is the largest health information technology company listed on the Australian Securities Exchange, and among the world's biggest providers of advanced application solutions in modern healthcare economies.

iSOFT works with healthcare professionals to design and build software applications that answer all of the difficult questions posed by today's healthcare delivery challenges. Our solutions act as a catalyst for change, supporting free exchange of critical information across diverse care settings and participating organizations.

Today, more than 13,000 provider organizations in over 40 countries use iSOFT's solutions to manage patient information and drive improvements in their core processes. The group's sustainable development is delivered through careful planning, in-depth analysis of the market, and anticipation of our clients' evolving requirements. Our business is driven by the collective talent, experience and commitment of more than 3,300 specialists in 19 countries worldwide.

A global network of iSOFT subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result, we offer our clients comprehensive knowledge of local market requirements in terms of culture, language, working practices, regulation and organizational structure.

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Routine AI Assistance may Lead to Loss o…

The introduction of artificial intelligence (AI) to assist colonoscopies is linked to a reduction in the ability of endoscopists (health professionals who perform colonoscopies) to detect precancerous growths (adenomas) in...